Shaker M - Search Results

1

Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis.

Chu DK, Abrams EM, Golden DBK, Blumenthal KG, Wolfson AR, Stone CA Jr, Krantz MS, Shaker M, Greenhawt M. Chu DK, et al. Among authors: shaker m. JAMA Intern Med. 2022 Apr 1;182(4):376-385. doi: 10.1001/jamainternmed.2021.8515. JAMA Intern Med. 2022. PMID: 35188528 Free PMC article.

2

Caregiver and expecting caregiver support for early peanut introduction guidelines.

Greenhawt M, Chan ES, Fleischer DM, Hicks A, Wilson R, Shaker M, Venter C, Stukus D. Greenhawt M, et al. Among authors: shaker m. Ann Allergy Asthma Immunol. 2018 Jun;120(6):620-625. doi: 10.1016/j.anai.2018.03.001. Epub 2018 Mar 7. Ann Allergy Asthma Immunol. 2018. PMID: 29524559

3

Summary and simulation of reported adverse events from epinephrine autoinjectors and a review of the literature.

Shaker M, Toy D, Lindholm C, Low J, Reigh E, Greenhawt M. Shaker M, et al. J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):2143-2145.e4. doi: 10.1016/j.jaip.2018.04.006. Epub 2018 Apr 13. J Allergy Clin Immunol Pract. 2018. PMID: 29660429 Review. No abstract available.

4

The Health and Economic Outcomes of Peanut Allergy Management Practices.

Shaker M, Greenhawt M. Shaker M, et al. J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):2073-2080. doi: 10.1016/j.jaip.2018.04.036. Epub 2018 May 8. J Allergy Clin Immunol Pract. 2018. PMID: 29751153

5

An economic evaluation of immediate vs non-immediate activation of emergency medical services after epinephrine use for peanut-induced anaphylaxis.

Shaker M, Kanaoka T, Feenan L, Greenhawt M. Shaker M, et al. Ann Allergy Asthma Immunol. 2019 Jan;122(1):79-85. doi: 10.1016/j.anai.2018.06.035. Epub 2018 Jul 17. Ann Allergy Asthma Immunol. 2019. PMID: 30025910

6

The health and economic outcomes of early egg introduction strategies.

Shaker M, Verma K, Greenhawt M. Shaker M, et al. Allergy. 2018 Nov;73(11):2214-2223. doi: 10.1111/all.13565. Allergy. 2018. PMID: 30028905

7

Association of Fatality Risk With Value-Based Drug Pricing of Epinephrine Autoinjectors for Children With Peanut Allergy: A Cost-effectiveness Analysis.

Shaker M, Greenhawt M. Shaker M, et al. JAMA Netw Open. 2018 Nov 2;1(7):e184728. doi: 10.1001/jamanetworkopen.2018.4728. JAMA Netw Open. 2018. PMID: 30646369 Free PMC article.

8

Estimation of Health and Economic Benefits of Commercial Peanut Immunotherapy Products: A Cost-effectiveness Analysis.

Shaker M, Greenhawt M. Shaker M, et al. JAMA Netw Open. 2019 May 3;2(5):e193242. doi: 10.1001/jamanetworkopen.2019.3242. JAMA Netw Open. 2019. PMID: 31050778 Free PMC article.

9

An update on allergic emergencies.

Toy D, Braga MS, Greenhawt M, Shaker M. Toy D, et al. Among authors: shaker m. Curr Opin Pediatr. 2019 Jun;31(3):426-432. doi: 10.1097/MOP.0000000000000769. Curr Opin Pediatr. 2019. PMID: 31090587 Review.

10

Providing cost-effective care for food allergy.

Shaker M, Greenhawt M. Shaker M, et al. Ann Allergy Asthma Immunol. 2019 Sep;123(3):240-248.e1. doi: 10.1016/j.anai.2019.05.015. Epub 2019 May 23. Ann Allergy Asthma Immunol. 2019. PMID: 31128233 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

455 results

Search Page